These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 27882487)

  • 1. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
    Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
    AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
    Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
    Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
    Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
    Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milk exosomes - Natural nanoparticles for siRNA delivery.
    Aqil F; Munagala R; Jeyabalan J; Agrawal AK; Kyakulaga AH; Wilcher SA; Gupta RC
    Cancer Lett; 2019 May; 449():186-195. PubMed ID: 30771430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmigration of Tetraspanin 2 (Tspan2) siRNA Via Microglia Derived Exosomes across the Blood Brain Barrier Modifies the Production of Immune Mediators by Microglia Cells.
    Reynolds JL; Mahajan SD
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):554-563. PubMed ID: 31823250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-Modified Tissue Engineered Blood Vessel for Endothelial Progenitor Cell Capture and Targeted siRNA Delivery.
    Chen W; Yang M; Bai J; Li X; Kong X; Gao Y; Bi L; Xiao L; Shi B
    Macromol Biosci; 2018 Feb; 18(2):. PubMed ID: 29205878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster of Differentiation 46 Is the Major Receptor in Human Blood-Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28).
    Kuroda H; Tachikawa M; Yagi Y; Umetsu M; Nurdin A; Miyauchi E; Watanabe M; Uchida Y; Terasaki T
    Mol Pharm; 2019 Jan; 16(1):292-304. PubMed ID: 30452273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of optimized liposomes for delivery of small interfering RNA.
    Yang T; Bantegui T; Pike K; Bloom R; Phipps R; Bai S
    J Liposome Res; 2014 Dec; 24(4):270-9. PubMed ID: 24708056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes are natural carriers of exogenous siRNA to human cells in vitro.
    Shtam TA; Kovalev RA; Varfolomeeva EY; Makarov EM; Kil YV; Filatov MV
    Cell Commun Signal; 2013 Nov; 11():88. PubMed ID: 24245560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
    Lunavat TR; Jang SC; Nilsson L; Park HT; Repiska G; Lässer C; Nilsson JA; Gho YS; Lötvall J
    Biomaterials; 2016 Sep; 102():231-8. PubMed ID: 27344366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic glioblastoma release exosomal VEGF-A induce the permeability of blood-brain barrier.
    Zhao C; Wang H; Xiong C; Liu Y
    Biochem Biophys Res Commun; 2018 Jul; 502(3):324-331. PubMed ID: 29787762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-mediated delivery of siRNA in vitro and in vivo.
    El-Andaloussi S; Lee Y; Lakhal-Littleton S; Li J; Seow Y; Gardiner C; Alvarez-Erviti L; Sargent IL; Wood MJ
    Nat Protoc; 2012 Dec; 7(12):2112-26. PubMed ID: 23154783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes.
    Wahlgren J; De L Karlson T; Brisslert M; Vaziri Sani F; Telemo E; Sunnerhagen P; Valadi H
    Nucleic Acids Res; 2012 Sep; 40(17):e130. PubMed ID: 22618874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
    Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
    Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
    Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes from iPSCs Delivering siRNA Attenuate Intracellular Adhesion Molecule-1 Expression and Neutrophils Adhesion in Pulmonary Microvascular Endothelial Cells.
    Ju Z; Ma J; Wang C; Yu J; Qiao Y; Hei F
    Inflammation; 2017 Apr; 40(2):486-496. PubMed ID: 28000095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.
    Nazarenko I; Rana S; Baumann A; McAlear J; Hellwig A; Trendelenburg M; Lochnit G; Preissner KT; Zöller M
    Cancer Res; 2010 Feb; 70(4):1668-78. PubMed ID: 20124479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
    Yang ZZ; Gao W; Liu YJ; Pang N; Qi XR
    Mol Pharm; 2017 Apr; 14(4):1012-1022. PubMed ID: 28252970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
    Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
    Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.